HomeLearnNews

News

March 22, 2017

Asbestos is a dangerous substance much like lead

Written by: The Mesothelioma Cancer Alliance It seems almost everyone today knows asbestos is a dangerous substance much like lead. If pressed however, it can be confusing why that is....
Read More
March 20, 2017

Drug Pricing Policy Summit forms working groups to move themes into action

Drug Pricing Policy Working Group Media Release For immediate release: TORONTO, ON - In November 2016, over 40 patient groups met in Toronto for the first Drug Pricing Policy in...
Read More
March 14, 2017

March 21 is Anal Cancer Awareness day

Read More
March 9, 2017

Watch our most recent webinar: New Diagnostics Guiding Oncology Treatment Decisions

Webinar Information: The Canadian Cancer Survivor Network was pleased to offer another webinar on precision medicine and diagnostic services, welcoming oncology and pathology centre expertise along with policy experts to...
Read More
March 2, 2017

Register for our upcoming webinar: New Diagnostics Guiding Oncology Treatment Decisions

Webinar Information: The Canadian Cancer Survivor Network is pleased to offer another webinar on precision medicine and diagnostic services, welcoming oncology and pathology centre expertise along with policy experts to...
Read More
March 1, 2017

Watch our most recent webinar: Healthcare in the Federal Budget and How It May Affect Patients

Webinar Information: The upcoming federal budget may contain announcements related to the way healthcare is funded in Canada, including changes to the regulation of pharmaceutical prices. Value for taxpayer money...
Read More
February 27, 2017

BC Pharmacare approves innohep

Effective February 14, 2017, BC Pharmacare has approved innohep for the additional indication of CAT for up to 6 months. For more information, please click here.
Read More
February 27, 2017

Making Canada Better, Innovative Medicines Canada Event Report

The following event report is the summary of Making Canada Better conference that was held this past November by Innovative Medicines Canada. Please click here to view the report.  
Read More
February 27, 2017

Webinar – Healthcare in the Federal Budget and How It May Affect Patients

Webinar Information: The upcoming federal budget may contain announcements related to the way healthcare is funded in Canada, including changes to the regulation of pharmaceutical prices. Value for taxpayer money...
Read More
February 21, 2017

CCSN Survey on Rituxan (Rituximab)

The purpose of this survey is to provide us with the needed insights and perspectives about the use of Rituxan (Rituximab) for the treatment of patients with Philadelphia chromosome-negative, CD20 antigen positive, B-cell precursor...
Read More
1 … 41 42 43 44 45 … 67